Introduction: The delivery bottleneck in CRISPR therapies CRISPR-based medicines hold the promise of treating a wide range of diseases, but their success hinges on effective delivery. Early efforts relied on viral vectors, especially adeno-associated viruses (AAVs), to ferry genetic material. While AAVs can deliver DNA, their payload size is limited and пациентов often develop immune…